1,000
Participants
Start Date
September 9, 2025
Primary Completion Date
September 30, 2040
Study Completion Date
September 30, 2040
Observational
Long Term Follow-Up for participants treated with TSC-100 or TSC-101 TCR-T products
RECRUITING
City of Hope, Duarte
RECRUITING
Mount Sinai, New York
TScan Therapeutics, Inc.
INDUSTRY